贝泰妮：（英文版）云南贝泰妮生物科技集团股份有限公司2024年年度报告摘要.PDF

1、Yunnan Botanee Bio-Technology Group Co.,Ltd.Summary of the 2024 Annual Report 1 Stock code:300957 Stock abbreviation:Botanee Announcement number:2025-007 Yunnan Botanee Biotechnology Group Co.,Ltd.Summary of the 2024 Annual Report I.Important Notice This annual report summary is derived from the ful

2、l text of the annual report.To fully understand the Companys operating results,financial status,and future development plans,investors should carefully read the full annual report on the media designated by the China Securities Regulatory Commission.All directors attended the Board meeting for delib

3、erating on this report.Tianheng Certified Public Accountants(Special General Partnership)issued a standard unqualified opinion on the Companys financial report for the year.Changes in the accounting firm during the reporting period Applicable Not applicable The Companys accounting firm for the 2024

4、fiscal year is Tianheng Certified Public Accountants(Special General Partnership).Notice of the non-standard audit opinion Applicable Not applicable The Company was not profitable at the time of its listing and has not achieved profitability to date.Applicable Not applicable Profit distribution plan

5、 or capital reserve transfer plan to increase capital approved by the board during the reporting period Applicable Not applicable The profit distribution plan approved by the Board during this meeting is:Based on the Companys total share capital of 423,600,000 shares,subtracting 2,307,118 shares in

6、the repurchase special account that do not participate in the profit distribution,i.e.,using 421,292,882 shares as the base,a cash dividend of CNY6.00(tax included)will be distributed for every 10 shares to all shareholders,with 0 bonus share(tax included)and 0 share for every 10 shares transferred